Lv11
50 积分 2025-12-08 加入
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
1个月前
已完结
胆道恶性肿瘤诊疗专家共识（2026版）
1个月前
已完结
Claudin-18.2 in Gastric and Gastroesophageal Junction Adenocarcinoma: From Biology to Therapeutic Targeting: A Narrative Review
1个月前
已完结
日间手术骨骼肌松弛药临床应用专家共识(2025版)
8个月前
已完结
皖公网安备34019202002308
